11.00

2.05% -0.23

After Hours: 10.79 -0.21 -1.91%

Day One Biopharmaceuticals Inc (DAWN)

Overview News Price History Option Chain Financials Discussions Forecast

Day One Biopharmaceuticals Inc stock is traded at $11.00, with a volume of 1.42M. It is down -2.05% in the last 24 hours and down -2.91% over the past month. Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.

Previous Close:

$11.23

Open:

$11.17

24h Volume:

1.42M

Relative Volume:

0.52

Market Cap:

$1.13B

Revenue:

$187.64M

Net Income/Loss:

$-95.00M

P/E Ratio:

-11.58

EPS:

-0.95

Net Cash Flow:

$-69.02M

1W Performance:

+4.96%

1M Performance:

-2.91%

6M Performance:

+79.15%

1Y Performance:

-9.32%

1-Day Range:

$10.76

$11.24

1-Week Range:

$10.76

$11.99

52-Week Range:

$5.635

$13.20

Day One Biopharmaceuticals Inc Stock (DAWN) Company Profile

Name

Day One Biopharmaceuticals Inc

Sector

Healthcare (1112)

Industry

Biotechnology (621)

Phone

650 484-0899

Address

1800 SIERRA POINT PARKWAY, SUITE 200, BRISBANE

Employee

181

Twitter

Next Earnings Date

Latest SEC Filings

DAWN's Discussions on Twitter

Compare DAWN vs VRTX, REGN, ARGX, ALNY, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DAWN Day One Biopharmaceuticals Inc	11.00	1.15B	187.64M	-95.00M	-69.02M	-0.95
VRTX Vertex Pharmaceuticals Inc	465.02	117.03B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	783.65	82.35B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	833.54	51.64B	3.06B	1.28B	447.35M	19.67
ALNY Alnylam Pharmaceuticals Inc	308.48	42.58B	3.21B	43.57M	221.36M	0.2405
ONC Beone Medicines Ltd Adr	346.42	38.87B	4.98B	69.60M	525.67M	0.5198

Day One Biopharmaceuticals Inc Stock (DAWN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-13-26	Resumed	TD Cowen	Buy
Aug-19-25	Initiated	Piper Sandler	Overweight
Oct-09-24	Reiterated	Needham	Buy
Aug-01-24	Upgrade	BofA Securities	Underperform → Buy
Apr-24-24	Reiterated	Needham	Buy
Apr-25-23	Downgrade	BofA Securities	Buy → Underperform
Feb-08-23	Initiated	CapitalOne	Overweight
Feb-03-23	Initiated	Oppenheimer	Perform
Dec-15-22	Initiated	H.C. Wainwright	Buy
Dec-14-22	Initiated	Needham	Buy
Dec-05-22	Initiated	Goldman	Buy
Dec-01-22	Initiated	BofA Securities	Buy

View All

Day One Biopharmaceuticals Inc Stock (DAWN) Latest News

Feb 11, 2026

FMR LLC Reduces Stake in Day One Biopharmaceuticals Inc - GuruFocus

Feb 11, 2026

Feb 10, 2026

Day One To Report Fourth Quarter and Full-Year 2025 Financial Results Tuesday, February 24, 2026 - GlobeNewswire

Feb 10, 2026

Feb 05, 2026

Aug Catalysts: Is Day One Biopharmaceuticals Inc a top pick in the sectorMarket Risk Report & Entry Point Strategy Guides - baoquankhu1.vn

Feb 05, 2026

Volume Summary: Is Day One Biopharmaceuticals Inc a top pick in the sectorEarnings Growth Summary & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn

Feb 05, 2026

Feb 02, 2026

Wall Street Analysts See a 101.08% Upside in Day One Biopharmaceuticals (DAWN): Can the Stock Really Move This High? - Finviz

Feb 02, 2026

Will Declining Medical Customers Affect Cigna's Q4 Earnings? - TradingView

Feb 02, 2026

AlphaQuest LLC Has $1.30 Million Stock Holdings in Day One Biopharmaceuticals, Inc. $DAWN - MarketBeat

Feb 02, 2026

Feb 01, 2026

Avoiding Lag: Real-Time Signals in (DAWN) Movement - Stock Traders Daily

Feb 01, 2026

Jan 31, 2026

Growth Report: How does Day One Biopharmaceuticals Inc compare to its peersPrice Action & Risk Controlled Swing Alerts - baoquankhu1.vn

Jan 31, 2026

Day One Biopharmaceuticals (DAWN) Investor Outlook: Unveiling A Potential 111% Upside - DirectorsTalk Interviews

Jan 31, 2026

Jan 30, 2026

A Look At Day One Biopharmaceuticals (DAWN) Valuation After Recent Share Price Momentum - Yahoo Finance

Jan 30, 2026

Jan 28, 2026

Day One Biopharmaceuticals (NASDAQ:DAWN) Upgraded to Strong-Buy at Zacks Research - MarketBeat

Jan 28, 2026

Will Day One Biopharmaceuticals Inc. face regulatory challenges2025 Historical Comparison & Free AI Powered Buy and Sell Recommendations - mfd.ru

Jan 28, 2026

Jan 27, 2026

Best Momentum Stocks to Buy for January 27th - Yahoo Finance

Jan 27, 2026

New Strong Buy Stocks for January 27th - Yahoo Finance

Jan 27, 2026

Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Jan 27, 2026

Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World

Jan 27, 2026

Jan 26, 2026

Is Day One Biopharmaceuticals Inc a top pick in the sectorQuarterly Profit Summary & Fast Entry High Yield Stock Tips - baoquankhu1.vn

Jan 26, 2026

Jan 24, 2026

AIGH Capital Management LLC Makes New Investment in Day One Biopharmaceuticals, Inc. $DAWN - MarketBeat

Jan 24, 2026

Jan 23, 2026